Brickell Biotech, Inc. Made Headway

Wed, Jun 29, 2022 at 08:16 PM
Brickell Biotech, Inc. Made Headway

Brickell Biotech, Inc. (BBI:NASDAQ) shot up at $0.17, representing a gain of 47.6%. On Wed, Jun 29, 2022, BBI:NASDAQ hit a New 2-Week High of $0.17. From Wed, Jun 15, 2022, the stock recorded 11.11% Up Days and 20.00% Green Days

The stock spiked on Wed, Jun 29, 2022 at $0.28 with a volume of 163M+.

About Brickell Biotech, Inc. (BBI:NASDAQ)

Brickell Biotech Inc is a United States-based clinical-stage pharmaceutical company focused on developing therapeutics for the treatment of skin diseases. Its pipeline consists of therapeutics for Hyperhidrosis, Cutaneous T-cell lymphoma, Psoriasis, and Other prevalent severe skin diseases. The company's pipeline products include Sofpironium Bromide, BBI-3000 and BBI-6000 among others.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.